TAG 6
Alternative Names: TAG-6Latest Information Update: 04 Apr 2003
At a glance
- Originator Unknown
- Developer AVI BioPharma
- Class
- Mechanism of Action Telomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Apr 2003 No development reported - Preclinical for Cancer in USA (unspecified route)
- 04 Jul 2000 New profile
- 04 Jul 2000 Preclinical development for Cancer in USA (Unknown route)